OTC · Medical - Pharmaceuticals

Adhera Therapeutics Inc (ATRX) Stock

$0.00 OTC: ATRX Healthcare

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes.

Valuation

MetricValue
Price$0.00
Market Cap$722
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-1.18
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.09%
ROA—
ROCE7.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.41
Current Ratio0.00

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-16.0M$-11.0M$-2.0M$-1.0M$-2.0M
Net Profit$-17.0M$-12.0M$-4.0M$-6.0M$-2.0M
EPS$-32.80$-24.80$-9.80$-12.84$-1.18
Op Margin-20732.2%-4490.5%———

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$5.0M$0$0$0$0
Total Liabilities$2.0M$10.0M$15.0M$25.0M$22.0M
Cash$4.0M$0$0$0$0
Borrowings$0$5.0M$6.0M$7.0M$9.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-10.0M$-9.0M$-1.0M$-1.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$6.0M$1.0M$1.0M$0
Net Cash Flow$4.0M$-4.0M$0$0$0
Free Cash Flow$-10.0M$-9.0M$-1.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-5.29
FCF Yield-195983.38%
Quick Ratio0.00
Interest Coverage-0.51
Return 1Y0.00%
Return 3Y-99.81%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CALACalithera Biosciences, Inc. $0.00 — 0.00 $487 0.00%
CNNXFCannAmerica Brands Corp. $0.00 — 0.00 $704 0.00%
EFTReFFECTOR Therapeutics, Inc. $0.00 — 0.00 $2352 0.00%
GBIMGlobeImmune, Inc. $0.00 — 0.00 — 0.00%
IMRSQIMRIS Inc. $0.00 — 0.00 — 0.00%

About Adhera Therapeutics Inc

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Adhera Therapeutics Inc (ATRX) stock trades at $0.00 with a market capitalization of $722. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Adhera Therapeutics Inc generates a return on equity (ROE) of 9.09%, return on capital employed of 7.29%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: adherathera.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides